Tag: Fortress Biotech
Zydus subsidiary supported drug data for Menkes disease set to be...
Fortress Biotech and Cyprium Therapeutics alongwith Zydus Lifesciences’ Sentynl Therapeutics announce CUTX-101, copper histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting